SVN-SDN-01425 Jul 2025 08:59
Is this the next expected news?
The remaining stages for the programme are as follows:
1. In-vitro screening for SERT, DAT and NET re-absorption inhibition
2. In-vitro screening for SERT, DAT and NET release - expected to complete by the end of July 2025
3. Pre-clinical animal testing
4. Lead candidate selection - expected by the end of Q3 2025